IRE1α-XBP1 signaling pathway, a potential therapeutic target in multiple myeloma
- 1 October 2016
- journal article
- review article
- Published by Elsevier in Leukemia Research
- Vol. 49, 7-12
Abstract
No abstract availableKeywords
Funding Information
- Key project supported by Tianjin Science and Technology
- Planned scientific research program of Tianjin Municipal Education Commission (20140112)
This publication has 71 references indexed in Scilit:
- Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicingBlood Cancer Journal, 2012
- Resveratrol triggers the pro-apoptotic endoplasmic reticulum stress response and represses pro-survival XBP1 signaling in human multiple myeloma cellsExperimental Hematology, 2011
- Antimyeloma Effects of the Heat Shock Protein 70 Molecular Chaperone Inhibitor MAL3-101Journal of Oncology, 2011
- Identification of novel myeloma-specific XBP1 peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myelomaLeukemia, 2011
- Potent and Selective Inhibitors of the Inositol-requiring Enzyme 1 EndoribonucleaseJournal of Biological Chemistry, 2011
- Regulation of unfolded protein response modulator XBP1s by acetylation and deacetylationBiochemical Journal, 2010
- Plasma cell differentiation initiates a limited ER stress response by specifically suppressing the PERK-dependent branch of the unfolded protein responseCell Stress and Chaperones, 2010
- XBP1 governs late events in plasma cell differentiation and is not required for antigen-specific memory B cell developmentJournal of Experimental Medicine, 2009
- Mediators of endoplasmic reticulum stress‐induced apoptosisEMBO Reports, 2006
- XBP1 mRNA Is Induced by ATF6 and Spliced by IRE1 in Response to ER Stress to Produce a Highly Active Transcription FactorCell, 2001